MacroGenics to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 23:00 pm UTC| Business
ROCKVILLE, MD, Feb. 09, 2017 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...
Medley Management Inc. Declares $0.20 Per Share Dividend for the Quarter Ended December 31, 2016
Feb 09, 2017 22:53 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Medley Management Inc. (NYSE:MDLY) (the "Company"), today announced that its Board of Directors declared a quarterly dividend of $0.20 per share of Class A Common stock for the fourth quarter...
Northern States Financial Corporation Reports 2016 Net Income of $2.1 million
Feb 09, 2017 22:42 pm UTC| Business
WAUKEGAN, Ill., Feb. 09, 2017 -- Northern States Financial Corporation (OTC PINK:NSFC) (the “Company”), holding company for NorStates Bank (the “Bank”), an FDIC insured financial institution, today reported annual net...
Tandy Leather Factory Names Tina L. Castillo, Chief Financial Officer and Treasurer
Feb 09, 2017 22:15 pm UTC| Business
FORT WORTH, Texas, Feb. 09, 2017 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) today announced that Tina L. Castillo has been promoted to Chief Financial Officer and Treasurer of the Company, effective February 7, 2017....
Feb 09, 2017 22:00 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed against Roadrunner Transportation Systems, Inc. (NYSE:RRTS) (“Roadrunner” or...
Feb 09, 2017 22:00 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a securities class action lawsuit has been filed against Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (Nasdaq:PETX) in the...
Feb 09, 2017 22:00 pm UTC| Business
NEW YORK and SAN DIEGO, Feb. 09, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a class action lawsuit has been filed against Regulus Therapeutics Inc. (“Regulus” or the “Company”) (NASDAQ:RGLS) in the...